Dymista (azelastine and fluticasone) nasal spray approved in Europe
Source: BioSpace
Area: News
Dymista (azelastine and fluticasone) nasal spray has been approved in Europe for the treatment of seasonal and perennial allergic rhinitis.. Efficacy and safety have been evaluated in several studies with over 4000 patients, including a long-term safety study with more than 600 patients. Launches are anticipated in 2013 in several countries.
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news